These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 32782366)

  • 1. The epigenomics of sarcoma.
    Nacev BA; Jones KB; Intlekofer AM; Yu JSE; Allis CD; Tap WD; Ladanyi M; Nielsen TO
    Nat Rev Cancer; 2020 Oct; 20(10):608-623. PubMed ID: 32782366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas.
    Siddiqi S; Mills J; Matushansky I
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):63-73. PubMed ID: 19807660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
    McBride MJ; Kadoch C
    J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in epigenetics and epigenomics for neurodegenerative diseases.
    Qureshi IA; Mehler MF
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):464-73. PubMed ID: 21671162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.
    Silverman BR; Shi J
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
    Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L
    Expert Opin Ther Targets; 2024; 28(1-2):17-28. PubMed ID: 38234142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
    Yusufova N; Kloetgen A; Teater M; Osunsade A; Camarillo JM; Chin CR; Doane AS; Venters BJ; Portillo-Ledesma S; Conway J; Phillip JM; Elemento O; Scott DW; Béguelin W; Licht JD; Kelleher NL; Staudt LM; Skoultchi AI; Keogh MC; Apostolou E; Mason CE; Imielinski M; Schlick T; David Y; Tsirigos A; Allis CD; Soshnev AA; Cesarman E; Melnick AM
    Nature; 2021 Jan; 589(7841):299-305. PubMed ID: 33299181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic dysregulation in cancer.
    Muntean AG; Hess JL
    Am J Pathol; 2009 Oct; 175(4):1353-61. PubMed ID: 19717641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell multi-modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma.
    Wang C; Huang W; Zhong Y; Zou X; Liu S; Li J; Sun Y; Zhou K; Chen X; Li Z; Wang S; Huang Y; Bai Y; Yin J; Jin X; Liu S; Yuan Y; Deng Q; Jiang M; Liu C; Liu L; Xu X; Wu L
    Clin Transl Med; 2024 Sep; 14(9):e70000. PubMed ID: 39210544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone modification: cause or cog?
    Henikoff S; Shilatifard A
    Trends Genet; 2011 Oct; 27(10):389-96. PubMed ID: 21764166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome dysregulation in cholangiocarcinoma.
    O'Rourke CJ; Munoz-Garrido P; Aguayo EL; Andersen JB
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1423-1434. PubMed ID: 28645654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Analysis in Ewing Sarcoma.
    Simon JM; Gomez NC
    Methods Mol Biol; 2021; 2226():285-302. PubMed ID: 33326110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.